China Considers 24-Hour Deadline for Recall of Seriously Harmful Drugs (China)
This article was originally published in PharmAsia News
In the wake of major recalls for two leukemia drugs, China's State Food and Drug Administration is drafting new rules for pharmaceutical manufacturers who suspect there may be a problem with their products. Under the new plan, recalled drugs would be grouped into three categories. In the first category are drugs that could have deadly or permanent effects. These drugs must be recalled within 24 hours. The second category includes drugs that could cause temporary damage and must be recalled within three days. The third category is reserved for labeling mistakes or other minor issues. Manufacturers would have seven days to enact these kinds of recalls. Chinese officials are still finalizing consequences for pharmaceutical companies found violating these rules. Proposed punishments include fines up to 50,000 yuan or the revocation of the company's production license. (Click here for more
You may also be interested in...
White House and HHS are increasing pressure on FDA Commissioner Hahn to clear Pfizer and Moderna’s COVID-19 vaccines as soon as possible – potentially skirting the advisory committee process. The move is leaving a last-minute political stain on a regulatory process the FDA fought hard to keep science-based and could foster a new wave of vaccine hesitancy amongst the American public.
Two physicians experienced in agency affairs and operations, former commissioner David Kessler and former principal deputy commissioner Joshua Sharfstein, are reportedly finalists to head Biden’s FDA.
Operation Warp Speed will hold back initial shipments to ensure two-dose regimens can be completed; 15 December is ‘chalk’ target date for emergency authorization of Pfizer vaccine, OWS’ Gustave Perna says, calling it only a projection that does not impinge on FDA authority. Sending only half shipments also eases burden on cold shortage capacity at state and local level, he says.